Response by Thuny et al to Letter Regarding Article, "Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity"

被引：1
|
作者：
Thuny, Franck [1 ,2 ,3 ,4 ]
Ederhy, Stephane [5 ]
Escudier, Marion [1 ,2 ,3 ,4 ]
Lalevee, Nathalie [2 ]
Cautela, Jennifer [1 ,2 ,3 ,4 ]
机构：
[1] Aix Marseille Univ, Hop Nord, AP HM,Dept Cardiol, Mediterranean Univ,Cardiooncol Ctr,Unit Heart Fai, Marseille, France
[2] Aix Marseille Univ, Ctr Rech Cardiovasc & Nutr, INSERM 1263, INRA, Marseille, France
[3] Grp Mediterraneen Cardiooncol, Marseille, France
[4] Aix Marseille Univ, AP HM, Oncosaftey Network Early Phases Canc Trials Ctr, Marseille, France
[5] Univ Paris 06, Hop Univ Paris Est, Hop St Antoine, Hop Tenon,AP HP,Inserm 856, Paris, France
来源：
CIRCULATION | 2018年 / 137卷 / 22期
关键词：
MYOCARDITIS;
D O I：
10.1161/CIRCULATIONAHA.118.033783
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2423 / 2424
页数：2
相关论文
共 50 条
  • [41] Response by Neeland et al to Letter Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management"
    Neeland, Ian J.
    Poirier, Paul
    Despres, Jean-Pierre
    CIRCULATION, 2018, 138 (14) : 1496 - 1497
  • [42] Clinical characteristics and management of immune checkpoint inhibitor-related pneumonitis: A single-institution retrospective study
    Wang, Hanping
    Zhao, Yanwei
    Zhang, Xiaotong
    Si, Xiaoyan
    Song, Peng
    Xiao, Yi
    Yang, Xu
    Song, Lan
    Shi, Juhong
    Zhao, Haitao
    Zhang, Li
    CANCER MEDICINE, 2021, 10 (01): : 188 - 198
  • [43] Clinical Characters and Influence Factors of Immune Checkpoint Inhibitor-related Thyroid Dysfunction
    Zhang, Qin
    Jiao, Xiaojuan
    Lai, Xiaoyang
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (11): : 2916 - 2923
  • [44] Letter regarding article by Armstrong et al, "Lessons learned from a clinical trial" - Response
    Armstrong, PW
    Newby, LK
    Granger, CB
    Lee, KL
    Califf, RM
    Simes, RJ
    Van de Werf, F
    CIRCULATION, 2005, 111 (23) : E393 - E393
  • [45] Radiologic features of immune checkpoint inhibitor-related nephritis with clinical correlation in biopsy-proven cases.
    Awiwi, Muhammad
    Abudayyeh, Ala
    Abdel-Wahab, Noha
    Diab, Adi
    Gjoni, Migena
    Xu, Guofan
    Vikram, Raghu
    Elsayes, Khaled M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [46] Letter by Sarayani et al Regarding Article, "Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque"
    Sarayani, Amir
    Jugl, Sebastian
    Winterstein, Almut G.
    CIRCULATION, 2021, 143 (25) : E1031 - E1032
  • [47] Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers
    Nobashi, Tomomi W.
    Nishimoto, Yuko
    Kawata, Yujiro
    Yutani, Hidetaka
    Nakamura, Masaki
    Tsuji, Yuichi
    Yoshida, Atsushi
    Sugimoto, Akihiko
    Yamamoto, Takayuki
    Alam, Israt S.
    Noma, Satoshi
    BRITISH JOURNAL OF RADIOLOGY, 2020, 93 (1115):
  • [48] Outcomes of Budesonide as a Treatment Option for Immune Checkpoint Inhibitor-Related Colitis in Patients with Cancer
    Machado, Antonio Pizuorno
    Shaikh, Abdullah Salim
    Saji, Alice
    Shatila, Malek
    Oliva, Isabella Glitza
    Wang, Yinghong
    Shirwaikar Thomas, Anusha
    CANCERS, 2024, 16 (10)
  • [49] Response by Benetos et al to Letter Regarding Article, "Hypertension Management in Older and Frail Older Patients"
    Benetos, Athanase
    Strandberg, Timo
    Petrovic, Mirko
    CIRCULATION RESEARCH, 2019, 125 (01) : E3 - E4
  • [50] Immune checkpoint inhibitor related neurologic adverse events: clinical spectrum, management and outcomes
    Dubey, Divyanshu
    David, William
    Reynolds, Kerry
    Chute, Donald
    Clement, Nathan Floyd
    Cohen, Justine V.
    Lawrence, Donald P.
    Mooradian, Meghan J.
    Sullivan, Ryan J.
    Guidon, Amanda
    NEUROLOGY, 2019, 92 (15)
12345